APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brucella Abortus Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Brucella Abortus Vaccine Market Outlook and Growth Opportunities 2026

21 December 2025211 pages

Choose your research edition.

Industry ResearchBrucella Abortus Vaccine Industry Research Report 2026146 pages · $2,950 USDIndustry Growth & TrendsGlobal Brucella Abortus Vaccine Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Brucella Abortus Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brucella Abortus Vaccine Market Outlook and Growth Opportunities 2026211 pages · $4,250 USDMarket Analysis & ForecastGlobal Brucella Abortus Vaccine Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Brucella Abortus Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brucella Abortus Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Brucella Abortus Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Brucella Abortus Vaccine market include Zoetis, Qilu Animal Health, Merck Animal Health, Vetal, VECOL, Tecnovax, SYVA Laboratorios, Onderstepoort Biological Products and Merial, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Brucella Abortus Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Brucella Abortus Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Brucella Abortus Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Brucella Abortus Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Brucella Abortus Vaccine Segment by Company

Zoetis

Qilu Animal Health

Merck Animal Health

Vetal

VECOL

Tecnovax

SYVA Laboratorios

Onderstepoort Biological Products

Merial

JOVAC

Instituto Rosenbusch

Institute of Animal Health and Veterinary Biologicals

Indian Immunologicals

Hester Biosciences

Dollvet

CZ Veterinaria

Colorado Serum Company

CEVA

Centro Diagnostico Veterinario

CAVAC

Biovet

Biogenesis Bago

Brucella Abortus Vaccine Segment by Type

Vector Vaccines

Subunit Vaccines

DNA Vaccines

B. Abortus Recombinant Mutants

Others

Brucella Abortus Vaccine Segment by Application

Pigs

Sheep

Cattles

Others

Brucella Abortus Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Brucella Abortus Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Brucella Abortus Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Brucella Abortus Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Brucella Abortus Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brucella Abortus Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brucella Abortus Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brucella Abortus Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Brucella Abortus Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Brucella Abortus Vaccine industry.

Chapter 3: Detailed analysis of Brucella Abortus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Brucella Abortus Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Brucella Abortus Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Brucella Abortus Vaccine Industry Trends Table 2. Brucella Abortus Vaccine Industry Drivers Table 3. Brucella Abortus Vaccine Industry Opportunities and Challenges Table 4. Brucella Abortus Vaccine Industry Restraints Table 5. Global Brucella Abortus Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Brucella Abortus Vaccine Revenue Share by Company (2021-2026) Table 7. Global Brucella Abortus Vaccine Sales Volume by Company (k units) & (2021-2026) Table 8. Global Brucella Abortus Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Brucella Abortus Vaccine Average Price (US$/unit) of Company (2021-2026) Table 10. Global Brucella Abortus Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Brucella Abortus Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Brucella Abortus Vaccine Company, Product Type & Application Table 13. Global Brucella Abortus Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Brucella Abortus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Vector Vaccines Table 18. Significant Companies of Subunit Vaccines Table 19. Significant Companies of DNA Vaccines Table 20. Significant Companies of B. Abortus Recombinant Mutants Table 21. Significant Companies of Others Table 22. Global Brucella Abortus Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 23. Global Brucella Abortus Vaccine Sales Volume by Type (2021-2026) & (k units) Table 24. Global Brucella Abortus Vaccine Sales Volume by Type (2027-2032) & (k units) Table 25. Global Brucella Abortus Vaccine Sales Volume Share by Type (2021-2026) Table 26. Global Brucella Abortus Vaccine Sales Volume Share by Type (2027-2032) Table 27. Global Brucella Abortus Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Brucella Abortus Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 29. Global Brucella Abortus Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 30. Global Brucella Abortus Vaccine Sales Value Share by Type (2021-2026) Table 31. Global Brucella Abortus Vaccine Sales Value Share by Type (2027-2032) Table 32. Significant Companies of Pigs Table 33. Significant Companies of Sheep Table 34. Significant Companies of Cattles Table 35. Significant Companies of Others Table 36. Global Brucella Abortus Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Brucella Abortus Vaccine Sales Volume by Application (2021-2026) & (k units) Table 38. Global Brucella Abortus Vaccine Sales Volume by Application (2027-2032) & (k units) Table 39. Global Brucella Abortus Vaccine Sales Volume Share by Application (2021-2026) Table 40. Global Brucella Abortus Vaccine Sales Volume Share by Application (2027-2032) Table 41. Global Brucella Abortus Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Brucella Abortus Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Brucella Abortus Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Brucella Abortus Vaccine Sales Value Share by Application (2021-2026) Table 45. Global Brucella Abortus Vaccine Sales Value Share by Application (2027-2032) Table 46. Global Brucella Abortus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Brucella Abortus Vaccine Sales by Region (2021-2026) & (k units) Table 48. Global Brucella Abortus Vaccine Sales Market Share by Region (2021-2026) Table 49. Global Brucella Abortus Vaccine Sales by Region (2027-2032) & (k units) Table 50. Global Brucella Abortus Vaccine Sales Market Share by Region (2027-2032) Table 51. Global Brucella Abortus Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Brucella Abortus Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Brucella Abortus Vaccine Sales Value Share by Region (2021-2026) Table 54. Global Brucella Abortus Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Brucella Abortus Vaccine Sales Value Share by Region (2027-2032) Table 56. Global Brucella Abortus Vaccine Market Average Price (US$/unit) by Region (2021-2026) Table 57. Global Brucella Abortus Vaccine Market Average Price (US$/unit) by Region (2027-2032) Table 58. Global Brucella Abortus Vaccine Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Brucella Abortus Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Brucella Abortus Vaccine Sales by Country (2021-2026) & (k units) Table 61. Global Brucella Abortus Vaccine Sales Market Share by Country (2021-2026) Table 62. Global Brucella Abortus Vaccine Sales by Country (2027-2032) & (k units) Table 63. Global Brucella Abortus Vaccine Sales Market Share by Country (2027-2032) Table 64. Global Brucella Abortus Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Brucella Abortus Vaccine Sales Value Market Share by Country (2021-2026) Table 66. Global Brucella Abortus Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Brucella Abortus Vaccine Sales Value Market Share by Country (2027-2032) Table 68. Zoetis Company Information Table 69. Zoetis Business Overview Table 70. Zoetis Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 71. Zoetis Brucella Abortus Vaccine Product Portfolio Table 72. Zoetis Recent Development Table 73. Qilu Animal Health Company Information Table 74. Qilu Animal Health Business Overview Table 75. Qilu Animal Health Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 76. Qilu Animal Health Brucella Abortus Vaccine Product Portfolio Table 77. Qilu Animal Health Recent Development Table 78. Merck Animal Health Company Information Table 79. Merck Animal Health Business Overview Table 80. Merck Animal Health Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 81. Merck Animal Health Brucella Abortus Vaccine Product Portfolio Table 82. Merck Animal Health Recent Development Table 83. Vetal Company Information Table 84. Vetal Business Overview Table 85. Vetal Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 86. Vetal Brucella Abortus Vaccine Product Portfolio Table 87. Vetal Recent Development Table 88. VECOL Company Information Table 89. VECOL Business Overview Table 90. VECOL Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 91. VECOL Brucella Abortus Vaccine Product Portfolio Table 92. VECOL Recent Development Table 93. Tecnovax Company Information Table 94. Tecnovax Business Overview Table 95. Tecnovax Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 96. Tecnovax Brucella Abortus Vaccine Product Portfolio Table 97. Tecnovax Recent Development Table 98. SYVA Laboratorios Company Information Table 99. SYVA Laboratorios Business Overview Table 100. SYVA Laboratorios Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 101. SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio Table 102. SYVA Laboratorios Recent Development Table 103. Onderstepoort Biological Products Company Information Table 104. Onderstepoort Biological Products Business Overview Table 105. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 106. Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio Table 107. Onderstepoort Biological Products Recent Development Table 108. Merial Company Information Table 109. Merial Business Overview Table 110. Merial Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 111. Merial Brucella Abortus Vaccine Product Portfolio Table 112. Merial Recent Development Table 113. JOVAC Company Information Table 114. JOVAC Business Overview Table 115. JOVAC Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 116. JOVAC Brucella Abortus Vaccine Product Portfolio Table 117. JOVAC Recent Development Table 118. Instituto Rosenbusch Company Information Table 119. Instituto Rosenbusch Business Overview Table 120. Instituto Rosenbusch Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 121. Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio Table 122. Instituto Rosenbusch Recent Development Table 123. Institute of Animal Health and Veterinary Biologicals Company Information Table 124. Institute of Animal Health and Veterinary Biologicals Business Overview Table 125. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 126. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio Table 127. Institute of Animal Health and Veterinary Biologicals Recent Development Table 128. Indian Immunologicals Company Information Table 129. Indian Immunologicals Business Overview Table 130. Indian Immunologicals Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 131. Indian Immunologicals Brucella Abortus Vaccine Product Portfolio Table 132. Indian Immunologicals Recent Development Table 133. Hester Biosciences Company Information Table 134. Hester Biosciences Business Overview Table 135. Hester Biosciences Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 136. Hester Biosciences Brucella Abortus Vaccine Product Portfolio Table 137. Hester Biosciences Recent Development Table 138. Dollvet Company Information Table 139. Dollvet Business Overview Table 140. Dollvet Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 141. Dollvet Brucella Abortus Vaccine Product Portfolio Table 142. Dollvet Recent Development Table 143. CZ Veterinaria Company Information Table 144. CZ Veterinaria Business Overview Table 145. CZ Veterinaria Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 146. CZ Veterinaria Brucella Abortus Vaccine Product Portfolio Table 147. CZ Veterinaria Recent Development Table 148. Colorado Serum Company Company Information Table 149. Colorado Serum Company Business Overview Table 150. Colorado Serum Company Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 151. Colorado Serum Company Brucella Abortus Vaccine Product Portfolio Table 152. Colorado Serum Company Recent Development Table 153. CEVA Company Information Table 154. CEVA Business Overview Table 155. CEVA Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 156. CEVA Brucella Abortus Vaccine Product Portfolio Table 157. CEVA Recent Development Table 158. Centro Diagnostico Veterinario Company Information Table 159. Centro Diagnostico Veterinario Business Overview Table 160. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 161. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio Table 162. Centro Diagnostico Veterinario Recent Development Table 163. CAVAC Company Information Table 164. CAVAC Business Overview Table 165. CAVAC Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 166. CAVAC Brucella Abortus Vaccine Product Portfolio Table 167. CAVAC Recent Development Table 168. Biovet Company Information Table 169. Biovet Business Overview Table 170. Biovet Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 171. Biovet Brucella Abortus Vaccine Product Portfolio Table 172. Biovet Recent Development Table 173. Biogenesis Bago Company Information Table 174. Biogenesis Bago Business Overview Table 175. Biogenesis Bago Brucella Abortus Vaccine Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 176. Biogenesis Bago Brucella Abortus Vaccine Product Portfolio Table 177. Biogenesis Bago Recent Development Table 178. Key Raw Materials Table 179. Raw Materials Key Suppliers Table 180. Brucella Abortus Vaccine Distributors List Table 181. Brucella Abortus Vaccine Customers List Table 182. Research Programs/Design for This Report Table 183. Authors List of This Report Table 184. Secondary Sources Table 185. Primary Sources List of Figures Figure 1. Brucella Abortus Vaccine Product Image Figure 2. Global Brucella Abortus Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Brucella Abortus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Brucella Abortus Vaccine Sales (2021-2032) & (k units) Figure 5. Global Brucella Abortus Vaccine Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global Brucella Abortus Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Vector Vaccines Image Figure 10. Subunit Vaccines Image Figure 11. DNA Vaccines Image Figure 12. B. Abortus Recombinant Mutants Image Figure 13. Others Image Figure 14. Global Brucella Abortus Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Brucella Abortus Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 16. Global Brucella Abortus Vaccine Sales Volume Share by Type (2021-2032) Figure 17. Global Brucella Abortus Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Brucella Abortus Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 19. Global Brucella Abortus Vaccine Sales Value Share by Type (2021-2032) Figure 20. Pigs Image Figure 21. Sheep Image Figure 22. Cattles Image Figure 23. Others Image Figure 24. Global Brucella Abortus Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Brucella Abortus Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Brucella Abortus Vaccine Sales Volume Share by Application (2021-2032) Figure 27. Global Brucella Abortus Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Brucella Abortus Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Brucella Abortus Vaccine Sales Value Share by Application (2021-2032) Figure 30. Global Brucella Abortus Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Brucella Abortus Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Brucella Abortus Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Brucella Abortus Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Brucella Abortus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. North America Brucella Abortus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Brucella Abortus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Brucella Abortus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Brucella Abortus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Brucella Abortus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Brucella Abortus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 41. South America Brucella Abortus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Brucella Abortus Vaccine Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Brucella Abortus Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Brucella Abortus Vaccine Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Brucella Abortus Vaccine Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Vector Vaccines
  • Subunit Vaccines
  • DNA Vaccines
  • B. Abortus Recombinant Mutants
  • Others
Applications
  • Pigs
  • Sheep
  • Cattles
  • Others
Companies covered
  • Zoetis
  • Qilu Animal Health
  • Merck Animal Health
  • Vetal
  • VECOL
  • Tecnovax
  • SYVA Laboratorios
  • Onderstepoort Biological Products
  • Merial
  • JOVAC
  • Instituto Rosenbusch
  • Institute of Animal Health and Veterinary Biologicals
  • Indian Immunologicals
  • Hester Biosciences
  • Dollvet
  • CZ Veterinaria
  • Colorado Serum Company
  • CEVA
  • Centro Diagnostico Veterinario
  • CAVAC
  • Biovet
  • Biogenesis Bago

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Brucella Abortus Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Brucella Abortus Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Brucella Abortus Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Brucella Abortus Vaccine Market Dynamics
  1. 2.1 Brucella Abortus Vaccine Industry Trends
  2. 2.2 Brucella Abortus Vaccine Industry Drivers
  3. 2.3 Brucella Abortus Vaccine Industry Opportunities and Challenges
  4. 2.4 Brucella Abortus Vaccine Industry Restraints
3 Brucella Abortus Vaccine Market by Company
  1. 3.1 Global Brucella Abortus Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Brucella Abortus Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Brucella Abortus Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Brucella Abortus Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Brucella Abortus Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Brucella Abortus Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Brucella Abortus Vaccine Company Product Type and Application
  8. 3.8 Global Brucella Abortus Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Brucella Abortus Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Brucella Abortus Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Brucella Abortus Vaccine Market by Type
  1. 4.1 Brucella Abortus Vaccine Type Introduction
  2. 4.1.1 Vector Vaccines
  3. 4.1.2 Subunit Vaccines
  4. 4.1.3 DNA Vaccines
  5. 4.1.4 B. Abortus Recombinant Mutants
  6. 4.1.5 Others
  7. 4.2 Global Brucella Abortus Vaccine Sales Volume by Type
  8. 4.2.1 Global Brucella Abortus Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Brucella Abortus Vaccine Sales Volume by Type (2021-2032)
  10. 4.2.3 Global Brucella Abortus Vaccine Sales Volume Share by Type (2021-2032)
  11. 4.3 Global Brucella Abortus Vaccine Sales Value by Type
  12. 4.3.1 Global Brucella Abortus Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Brucella Abortus Vaccine Sales Value by Type (2021-2032)
  14. 4.3.3 Global Brucella Abortus Vaccine Sales Value Share by Type (2021-2032)
5 Brucella Abortus Vaccine Market by Application
  1. 5.1 Brucella Abortus Vaccine Application Introduction
  2. 5.1.1 Pigs
  3. 5.1.2 Sheep
  4. 5.1.3 Cattles
  5. 5.1.4 Others
  6. 5.2 Global Brucella Abortus Vaccine Sales Volume by Application
  7. 5.2.1 Global Brucella Abortus Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Brucella Abortus Vaccine Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Brucella Abortus Vaccine Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Brucella Abortus Vaccine Sales Value by Application
  11. 5.3.1 Global Brucella Abortus Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Brucella Abortus Vaccine Sales Value by Application (2021-2032)
  13. 5.3.3 Global Brucella Abortus Vaccine Sales Value Share by Application (2021-2032)
6 Brucella Abortus Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Brucella Abortus Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Brucella Abortus Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Brucella Abortus Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Brucella Abortus Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Brucella Abortus Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Brucella Abortus Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Brucella Abortus Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Brucella Abortus Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Brucella Abortus Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Brucella Abortus Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Brucella Abortus Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Brucella Abortus Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Brucella Abortus Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Brucella Abortus Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Brucella Abortus Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Brucella Abortus Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Brucella Abortus Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Brucella Abortus Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Brucella Abortus Vaccine Sales Value Share by Country, 2025 VS 2032
7 Brucella Abortus Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Brucella Abortus Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Brucella Abortus Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Brucella Abortus Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Brucella Abortus Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Brucella Abortus Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Brucella Abortus Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Brucella Abortus Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Brucella Abortus Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Brucella Abortus Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Brucella Abortus Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Brucella Abortus Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Brucella Abortus Vaccine Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Qilu Animal Health
  8. 8.2.1 Qilu Animal Health Company Information
  9. 8.2.2 Qilu Animal Health Business Overview
  10. 8.2.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Qilu Animal Health Brucella Abortus Vaccine Product Portfolio
  12. 8.2.5 Qilu Animal Health Recent Developments
  13. 8.3 Merck Animal Health
  14. 8.3.1 Merck Animal Health Company Information
  15. 8.3.2 Merck Animal Health Business Overview
  16. 8.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Merck Animal Health Brucella Abortus Vaccine Product Portfolio
  18. 8.3.5 Merck Animal Health Recent Developments
  19. 8.4 Vetal
  20. 8.4.1 Vetal Company Information
  21. 8.4.2 Vetal Business Overview
  22. 8.4.3 Vetal Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Vetal Brucella Abortus Vaccine Product Portfolio
  24. 8.4.5 Vetal Recent Developments
  25. 8.5 VECOL
  26. 8.5.1 VECOL Company Information
  27. 8.5.2 VECOL Business Overview
  28. 8.5.3 VECOL Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 VECOL Brucella Abortus Vaccine Product Portfolio
  30. 8.5.5 VECOL Recent Developments
  31. 8.6 Tecnovax
  32. 8.6.1 Tecnovax Company Information
  33. 8.6.2 Tecnovax Business Overview
  34. 8.6.3 Tecnovax Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Tecnovax Brucella Abortus Vaccine Product Portfolio
  36. 8.6.5 Tecnovax Recent Developments
  37. 8.7 SYVA Laboratorios
  38. 8.7.1 SYVA Laboratorios Company Information
  39. 8.7.2 SYVA Laboratorios Business Overview
  40. 8.7.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 SYVA Laboratorios Brucella Abortus Vaccine Product Portfolio
  42. 8.7.5 SYVA Laboratorios Recent Developments
  43. 8.8 Onderstepoort Biological Products
  44. 8.8.1 Onderstepoort Biological Products Company Information
  45. 8.8.2 Onderstepoort Biological Products Business Overview
  46. 8.8.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Onderstepoort Biological Products Brucella Abortus Vaccine Product Portfolio
  48. 8.8.5 Onderstepoort Biological Products Recent Developments
  49. 8.9 Merial
  50. 8.9.1 Merial Company Information
  51. 8.9.2 Merial Business Overview
  52. 8.9.3 Merial Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Merial Brucella Abortus Vaccine Product Portfolio
  54. 8.9.5 Merial Recent Developments
  55. 8.10 JOVAC
  56. 8.10.1 JOVAC Company Information
  57. 8.10.2 JOVAC Business Overview
  58. 8.10.3 JOVAC Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 JOVAC Brucella Abortus Vaccine Product Portfolio
  60. 8.10.5 JOVAC Recent Developments
  61. 8.11 Instituto Rosenbusch
  62. 8.11.1 Instituto Rosenbusch Company Information
  63. 8.11.2 Instituto Rosenbusch Business Overview
  64. 8.11.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Instituto Rosenbusch Brucella Abortus Vaccine Product Portfolio
  66. 8.11.5 Instituto Rosenbusch Recent Developments
  67. 8.12 Institute of Animal Health and Veterinary Biologicals
  68. 8.12.1 Institute of Animal Health and Veterinary Biologicals Company Information
  69. 8.12.2 Institute of Animal Health and Veterinary Biologicals Business Overview
  70. 8.12.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product Portfolio
  72. 8.12.5 Institute of Animal Health and Veterinary Biologicals Recent Developments
  73. 8.13 Indian Immunologicals
  74. 8.13.1 Indian Immunologicals Company Information
  75. 8.13.2 Indian Immunologicals Business Overview
  76. 8.13.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Indian Immunologicals Brucella Abortus Vaccine Product Portfolio
  78. 8.13.5 Indian Immunologicals Recent Developments
  79. 8.14 Hester Biosciences
  80. 8.14.1 Hester Biosciences Company Information
  81. 8.14.2 Hester Biosciences Business Overview
  82. 8.14.3 Hester Biosciences Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hester Biosciences Brucella Abortus Vaccine Product Portfolio
  84. 8.14.5 Hester Biosciences Recent Developments
  85. 8.15 Dollvet
  86. 8.15.1 Dollvet Company Information
  87. 8.15.2 Dollvet Business Overview
  88. 8.15.3 Dollvet Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Dollvet Brucella Abortus Vaccine Product Portfolio
  90. 8.15.5 Dollvet Recent Developments
  91. 8.16 CZ Veterinaria
  92. 8.16.1 CZ Veterinaria Company Information
  93. 8.16.2 CZ Veterinaria Business Overview
  94. 8.16.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 CZ Veterinaria Brucella Abortus Vaccine Product Portfolio
  96. 8.16.5 CZ Veterinaria Recent Developments
  97. 8.17 Colorado Serum Company
  98. 8.17.1 Colorado Serum Company Company Information
  99. 8.17.2 Colorado Serum Company Business Overview
  100. 8.17.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Colorado Serum Company Brucella Abortus Vaccine Product Portfolio
  102. 8.17.5 Colorado Serum Company Recent Developments
  103. 8.18 CEVA
  104. 8.18.1 CEVA Company Information
  105. 8.18.2 CEVA Business Overview
  106. 8.18.3 CEVA Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 CEVA Brucella Abortus Vaccine Product Portfolio
  108. 8.18.5 CEVA Recent Developments
  109. 8.19 Centro Diagnostico Veterinario
  110. 8.19.1 Centro Diagnostico Veterinario Company Information
  111. 8.19.2 Centro Diagnostico Veterinario Business Overview
  112. 8.19.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Product Portfolio
  114. 8.19.5 Centro Diagnostico Veterinario Recent Developments
  115. 8.20 CAVAC
  116. 8.20.1 CAVAC Company Information
  117. 8.20.2 CAVAC Business Overview
  118. 8.20.3 CAVAC Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 CAVAC Brucella Abortus Vaccine Product Portfolio
  120. 8.20.5 CAVAC Recent Developments
  121. 8.21 Biovet
  122. 8.21.1 Biovet Company Information
  123. 8.21.2 Biovet Business Overview
  124. 8.21.3 Biovet Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Biovet Brucella Abortus Vaccine Product Portfolio
  126. 8.21.5 Biovet Recent Developments
  127. 8.22 Biogenesis Bago
  128. 8.22.1 Biogenesis Bago Company Information
  129. 8.22.2 Biogenesis Bago Business Overview
  130. 8.22.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Value and Gross Margin (2021-2026)
  131. 8.22.4 Biogenesis Bago Brucella Abortus Vaccine Product Portfolio
  132. 8.22.5 Biogenesis Bago Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Brucella Abortus Vaccine Value Chain Analysis
  2. 9.1.1 Brucella Abortus Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Brucella Abortus Vaccine Sales Mode & Process
  6. 9.2 Brucella Abortus Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Brucella Abortus Vaccine Distributors
  9. 9.2.3 Brucella Abortus Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst